Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parrott

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
The AAPS Journal|May 28, 2020
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of EntrectinibNeil Parrott, Cordula Stillhart, Marc Lindenberg, et al.
Clinical Pharmacology and Therapeutics|April 5, 2023
Dose Adjustment in Patients with Liver Cirrhosis - Comparison of Two Different Modeling ApproachesAgustos C Ozbey, Fabio Bachmann, Urs Duthaler, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Model-Based Assessments of CYP-Mediated Drug-Drug Interaction Risk of Alectinib: Physiologically Based Pharmacokinetic Modeling Supported Clinical DevelopmentYumi Cleary, Michael Gertz, Peter N Morcos, et al.
Molecular Pharmaceutics|February 27, 2013
In vitro to in vivo extrapolation and physiologically based modeling of cytochrome P450 mediated metabolism in beagle dog gut wall and liverAki T Heikkinen, Stephen Fowler, Lynn Gray, et al.
Pharmaceutical Research|July 30, 2016
Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
Pharmaceutical Research|August 24, 2016
Erratum to: Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
Clinical Pharmacology and Therapeutics|February 1, 2021
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus DrugValérie Cosson, Sheng Feng, Felix Jaminion, et al.
Pediatric Nephrology (Berlin, Germany)|February 7, 2008
Successful renal transplantation in children in the presence of thrombosis of the inferior vena cavaMohan Shenoy, Ravi Pararajasingam, Neville B Wright, et al.
European Journal of Clinical Pharmacology|March 25, 2015
Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathwaySheng Feng, Yumi Cleary, Neil Parrott, et al.
The AAPS Journal|November 6, 2020
Correction to: In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human HepatocytesLuca Docci, Florian Klammers, Aynur Ekiciler, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
The AAPS Journal|May 28, 2020
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of EntrectinibNeil Parrott, Cordula Stillhart, Marc Lindenberg, et al.
Clinical Pharmacology and Therapeutics|April 5, 2023
Dose Adjustment in Patients with Liver Cirrhosis - Comparison of Two Different Modeling ApproachesAgustos C Ozbey, Fabio Bachmann, Urs Duthaler, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Model-Based Assessments of CYP-Mediated Drug-Drug Interaction Risk of Alectinib: Physiologically Based Pharmacokinetic Modeling Supported Clinical DevelopmentYumi Cleary, Michael Gertz, Peter N Morcos, et al.
Molecular Pharmaceutics|February 27, 2013
In vitro to in vivo extrapolation and physiologically based modeling of cytochrome P450 mediated metabolism in beagle dog gut wall and liverAki T Heikkinen, Stephen Fowler, Lynn Gray, et al.
Pharmaceutical Research|July 30, 2016
Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
Pharmaceutical Research|August 24, 2016
Erratum to: Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo ApproachFloriane Lignet, Eva Sherbetjian, Nicole Kratochwil, et al.
Clinical Pharmacology and Therapeutics|February 1, 2021
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus DrugValérie Cosson, Sheng Feng, Felix Jaminion, et al.
Pediatric Nephrology (Berlin, Germany)|February 7, 2008
Successful renal transplantation in children in the presence of thrombosis of the inferior vena cavaMohan Shenoy, Ravi Pararajasingam, Neville B Wright, et al.
European Journal of Clinical Pharmacology|March 25, 2015
Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathwaySheng Feng, Yumi Cleary, Neil Parrott, et al.
The AAPS Journal|November 6, 2020
Correction to: In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human HepatocytesLuca Docci, Florian Klammers, Aynur Ekiciler, et al.
Pageof 13